Table II.
S. aureus strains used in the experiments and MIC.
| MIC (µg/ml) | ||||||||
|---|---|---|---|---|---|---|---|---|
| S. aureus strain | Class | ORV | AM | OX | VC | GT | NR | CP |
| ATCC 25923 | MSSA | 125 | 31.25 | 125 | 3.9 | 62.5 | 15.6 | 31.25 |
| ATCC 33591 | MRSA | 125 | 1,000 | 500 | 1.95 | 31.25 | 250 | 500 |
| DPS-1 | MRSA | 125 | 1,000 | 1,000 | 1.95 | 250 | 31.25 | 125 |
| DPS-2 | MRSA | 125 | 1,000 | 1,000 | 3.9 | 125 | 31.25 | 125 |
| DPS-3 | MRSA | 125 | 1,000 | 1,000 | 1.95 | 125 | 31.25 | 125 |
S. aureus, Staphylococcus aureus; MIC, minimum inhibitory concentration; ORV, oxyresveratrol; AM, ampicillin; OX, oxacillin; VC, vancomycin; GT, gentamicin; NR, norfloxacin; CP, ciprofloxacin; ATCC, American Type Culture Collection; MSSA, methicillin-sensitive S. aureus; MRSA, methicillin-resistant S. aureus; DPS, strain from the Department of Plastic Surgery, Wonkwang University Hospital.